Q32 Bio Inc. (QTTB) Other financing activities (2018 - 2024)

Q32 Bio has reported Other financing activities for 7 years, with the latest figure at $317000.0 in Q4 2024.

• On a quarterly basis, Other financing activities rose 317.11% year-over-year to $317000.0 in Q4 2024; TTM through Dec 2025 was $1.3 million, a 22.43% decrease from a year earlier, with the FY2024 full-year figure at $1.7 million, up 1498.11% from the prior year.
• Other financing activities was $317000.0 for Q4 2024 at Q32 Bio, down from $997000.0 in the prior quarter.
• The five-year high for Other financing activities was $51.0 million in Q4 2020, with the low at $1000.0 in Q4 2021.
• Average Other financing activities over 5 years is $3.7 million, with a median of $379000.0 recorded in 2021.
• The sharpest annual moves came in 2021 and 2022: Other financing activities plunged 100.0% in 2021, then soared 3100.0% in 2022.
• Over 5 years, Other financing activities stood at $51.0 million in 2020, then slumped by 100.0% to $1000.0 in 2021, then jumped by 3100.0% to $32000.0 in 2022, then soared by 137.5% to $76000.0 in 2023, then soared by 317.11% to $317000.0 in 2024.
• The last three Other financing activities figures came in at $317000.0 (Q4 2024), $997000.0 (Q3 2024), and $380000.0 (Q2 2024), per Business Quant data.